Anti-PGAP1 monoclonal antibody

Pre-made anti-PGAP1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PGAP1/PGAP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1378-Ab-1/ GM-Tg-hg-IP1378-Ab-2Anti-Human PGAP1 monoclonal antibodyHuman
GM-Tg-rg-IP1378-Ab-1/ GM-Tg-rg-IP1378-Ab-2Anti-Rat PGAP1 monoclonal antibodyRat
GM-Tg-mg-IP1378-Ab-1/ GM-Tg-mg-IP1378-Ab-2Anti-Mouse PGAP1 monoclonal antibodyMouse
GM-Tg-cynog-IP1378-Ab-1/ GM-Tg-cynog-IP1378-Ab-2Anti-Cynomolgus/ Rhesus macaque PGAP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1378-Ab-1/ GM-Tg-felg-IP1378-Ab-2Anti-Feline PGAP1 monoclonal antibodyFeline
GM-Tg-cang-IP1378-Ab-1/ GM-Tg-cang-IP1378-Ab-2Anti-Canine PGAP1 monoclonal antibodyCanine
GM-Tg-bovg-IP1378-Ab-1/ GM-Tg-bovg-IP1378-Ab-2Anti-Bovine PGAP1 monoclonal antibodyBovine
GM-Tg-equg-IP1378-Ab-1/ GM-Tg-equg-IP1378-Ab-2Anti-Equine PGAP1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1378-Ab-1/ GM-Tg-hg-IP1378-Ab-2; GM-Tg-rg-IP1378-Ab-1/ GM-Tg-rg-IP1378-Ab-2;
GM-Tg-mg-IP1378-Ab-1/ GM-Tg-mg-IP1378-Ab-2; GM-Tg-cynog-IP1378-Ab-1/ GM-Tg-cynog-IP1378-Ab-2;
GM-Tg-felg-IP1378-Ab-1/ GM-Tg-felg-IP1378-Ab-2; GM-Tg-cang-IP1378-Ab-1/ GM-Tg-cang-IP1378-Ab-2;
GM-Tg-bovg-IP1378-Ab-1/ GM-Tg-bovg-IP1378-Ab-2; GM-Tg-equg-IP1378-Ab-1/ GM-Tg-equg-IP1378-Ab-2
Products NameAnti-PGAP1 monoclonal antibody
Formatmab
Target NamePGAP1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PGAP1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1378-Ag-1Recombinant multi-species PGAP1/ Bst1/ ISPD3024 protein


    Target information

    Target IDGM-IP1378
    Target NamePGAP1
    Gene ID80055,241062,316400,696475,612828,101083194,504677,100070459
    Gene Symbol and Synonyms5033403E17Rik,9030223K07Rik,A530084K22,Bst1,D230012E17Rik,ISPD3024,MRT42,NEDDSBA,oto,PGAP1,SPG67
    Uniprot AccessionQ75T13,Q765A7
    Uniprot Entry NamePGAP1_HUMAN,PGAP1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000197121
    Target ClassificationN/A

    The target: PGAP1, gene name: PGAP1, also named as Bst1, ISPD3024, MRT42, SPG67. The protein encoded by this gene functions early in the glycosylphosphatidylinositol (GPI) biosynthetic pathway, catalyzing the inositol deacylation of GPI. The encoded protein is required for the production of GPI that can attach to proteins, and this may be an important factor in the transport of GPI-anchored proteins from the endoplasmic reticulum to the Golgi. Defects in this gene are a cause an autosomal recessive form of cognitive impairment. [provided by RefSeq, Jul 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.